Therefore, postnatal L-carnitine deficiency may lead to impaired fatty acid oxidation, resulting in clinical manifestations of hypoglycemia, hypothermia, acidosis and infection
For CIDP, evidence is also emerging that patients previously maintained on IVIg treatment may undergo disease worsening upon switching to FcRn antagonists, underlining the fact that other disease drivers than solely auto-Abs are also vital aspects of pathophysiology in at least certain patients with CIDP [265, 401, 402]
Baykal, C., Ylmaz, Z., Sun, G
10.1016/j.tcb.2011.06.008 [DOI] [PMC free article] [PubMed] [Google Scholar] Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A
Immune checkpoint dysfunction in large and medium vessel vasculitis